Trademarkia Logo

Canada

C$
Trademark Search in Canada
ORYX

View On IC.GC.CA

ORYX
REGISTERED

on 11 Jan 2022

Last Applicant/ Owned by

ORYX VERWALTUNGS GMBH

Markplatz 185598 Baldham

DE

Serial Number

1819047 filed on 20th Jan 2017

Registration Number

TMA1117383 registered on 11th Jan 2022

Registration expiry Date

11th Jan 2032

Correspondent Address

MLT AIKINS LLP

2100 Livingston Place222-3rd Avenue SWCalgary

ALBERTA

CA

T2P0B4

ORYX

Trademark usage description

pharmaceutical and veterinary preparations for the treatment of cancer, autoimmune and neurodegenerative diseases and diseases of the central nervous Read More

Classification Information

Class [005]
Pharmaceutical and veterinary preparations for the treatment of cancer, autoimmune and neurodegenerative diseases and diseases of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases;

Classification kind code

11

Class [035]
Business administration; business consultancy in the fields of treatment of cancer, autoimmune and neurodegenerative diseases and diseases of the central nervous system; personnel consultancy and personnel management consultancy; office functions, namely, accounting services, bookkeeping, document reproduction, payroll preparation, photocopying, word processing services; organization of trade fairs for commercial and advertising purposes in relation to financial support for research and development of translational medicine projects and drug development; compilation of data in electronic databases containing information in relation to research and development on the treatment of cancer, autoimmune and neurodegenerative diseases and diseases of the central nervous system;

Classification kind code

11

Class [036]
Development of usage concepts for intellectual property with regard to financial matters, namely, advising others regarding intellectual property investments; financial sponsorship of research and development of pharmaceutical and veterinary preparations for the treatment of cancer and autoimmune and neurodegenerative diseases and diseases of the central nervous system; advising others concerning investments in intellectual property assets and intangible business assets, both directly and indirectly through other entities;

Classification kind code

11

Class [042]
Scientific and technological services, namely, scientific research, analysis and testing in the field of pharmaceutical and veterinary preparations for the treatment of cancer, autoimmune and neurodegenerative diseases and diseases of the central nervous system;

Classification kind code

11

Class [045]
Consulting services in the field of managing intellectual properties;

Classification kind code

11

Mark Details

Serial Number

1819047

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 10th Aug 2021		Approved
Submitted for opposition 15
on 15th Dec 2020		Correspondence Created
Submitted for opposition 15
on 26th Sept 2019		Correspondence Created
Submitted for opposition 15
on 10th Jan 2019		Correspondence Created
Submitted for opposition 15
on 29th Aug 2018		Correspondence Created
Submitted for opposition 22
on 27th Oct 2017		Search Recorded
Submitted for opposition 20
on 27th Oct 2017		Examiner's First Report
Submitted for opposition 31
on 24th Jan 2017		Formalized
Submitted for opposition 1
on 23rd Jan 2017		Created
Submitted for opposition 30
on 20th Jan 2017		Filed